PBH
Prestige Consumer Healthcare In
Drug Manufacturers - Specialty & Generic · Healthcare · United States
51.32
close · 2026-08-13
value
76
cheaper than peers76
quality
67
stronger fundamentals67
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
34 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 1.29× | 84 |
| forward P/E | 10.10× | 72 |
| EV to EBITDA | 13.48× | 52 |
3 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 24.6% | 84 |
| return on equity | 9.1% | 63 |
| revenue growth | 6.5% | 45 |
| debt to equity | 107.7% | 43 |
4 of 4 measures available
Facts
| market cap | $2B |
| free cash flow | $160.6M |
| employees | 890 |
| first trade | 2005-02-10 |
| next earnings | 2026-08-06 |
| fundamentals updated | 2026-08-07 |